SAN DIEGO (MedPage Today) -- Women who had surgically induced menopause at an early age saw a decline in cognitive function and possible signs of Alzheimer's disease pathology, researchers reported here.
Medication: Depression. Major depressive disorder has significant potential morbidity and mortality, contributing to suicide, incidence and adverse outcomes of medical illness, disruption in interpersonal relationships, substance abuse, and lost work time.
Premalignant Lesions of the Endometrium. Endometrial hyperplasia involves the proliferation of endometrial glands that results in a greater than normal gland-to-stroma ratio.
The 5th IVI International Congress: Reproductive Medicine and Beyond by ComtecMed 04-Apr-13 to 06-Apr-13 Seville , SPAIN (GYN - Contraception & Reproductive Health)
2013 AIUM Annual Convention by American Institute of Ultrasound in Medicine 06-Apr-13 to 10-Apr-13 New York (New York Marriott Marquis Hotel) , NY USA (CME - Medical Education)
Manejo clínico y terapéutico de la esterilidad. Segundo curso online by Fundacio Dexeus Salud de la Mujer 09-Apr-13 to 31-May-13 online , SPAIN(gynecology)
Pediatric Nursing: Care of the Hospitalized Child by Continuing Education Inc. 10-Apr-13 to 13-Apr-13 Anaheim (Hyatt Regency Orange County) , CA USA (CME - Obstetrics, Gynecology & Women's Health)
Medicina fetal Curso-Taller. Curso de Nivel I y II de la SESEGO by Fundacio Dexeus Salud de la Mujer 15-Apr-13 to 17-Apr-13 Barcelona (Auditorio Salud de la Mujer Dexeus) , SPAIN (OB - Maternal Fetal Medicine)
Female Urology & Urogynecology Symposium (FUUS) by Quadrant HealthCom, Inc 18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)
Female Urology and Urogynecology Symposium (FUUS) 2013 by Quadrant HealthCom, Inc 18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)
In a new study, women who initiated hormone replacement therapy soon after beginning menopause and who continued treatment for 10 years had significantly reduced risk of myocardial infarction, heart failure, or death with no increased risk of cancer, venous thromboembolism, or stroke. More »
The claims that compounded bioidentical hormones are superior to conventional menopausal hormone therapy are unsupported by evidence, according to a new committee review of compounded bioidentical menopausal hormone therapy. More »
The U.S. Preventive Services Task Force has issued draft recommendations for postmenopausal hormone therapy for the primary prevention of chronic conditions, such as heart
disease, stroke, dementia, hip fracture, and breast cancer. More »
In a highly critical re-analysis of the Women’s Health Initiative (WHI) study of 2002, the results of which prompted safety fears about hormone replacement therapy (HRT) significantly increasing the risk of breast cancer, it was concluded that the weight of evidence supports benefits over risks for... More »
Women who experience early menopause are almost twice as likely to have osteoporosis and are at greater risk for fracture and death than women who experience menopause later in life, according to results of a 34-year study conducted in Sweden. More »
An increased loss of bone density during the first years after menopause induces osteoporosis.|The aim of the research presented in this paper was to ascertain the difference in the rate of involutional changes in bone tissue in former athletes and in non-athletes of the same age.|The research involved 18 former swimmers and 18 females of similar age who had never practiced sports. The subjects were subdivided into two subgroups: Subgroup I had been post-menopausal for < or = 5 years, and Subgroup II for > 5 years; this was done to assess bone mineral content relative to the length of the postmenopausal time period. Bone mineral content (BMC) and bone mineral density (BMD) were measured in lumbar vertebrae by dual-emission X-ray absorptiometry (DXA). Bone strength was measured in the heel using the bone stiffness index. Each subject was examined twice, with a one-year period in between. A diagnostic questionnaire was used to compile date on the subjects' physical activity and their
Hyperandrogenism, insulin resistance, and altered adipocytokine levels characterize polycystic ovary syndrome (PCOS) women of reproductive age. Hyperandrogenism persists in postmenopausal PCOS women. In the latter, this study aimed at investigating carbohydrate metabolism, adipocytokines, androgens, and their relationships.|Blood sampling from overweight postmenopausal women (25 PCOS and 24 age- and BMI-matched controls) at baseline and during oral glucose tolerance test for measurement of insulin and glucose levels, baseline leptin, adiponectin, visfatin, retinol-binding protein 4, lipocalin-2, androgen, and high-sensitivity C-reactive protein (hs-CRP) levels and for calculation of insulin sensitivity (glucose-to-insulin ratio (G/I), quantitative insulin sensitivity check index, and insulin sensitivity index (ISI)), resistance (homeostasis mathematical model assessment-insulin resistance (HOMA-IR)), secretion ( of the area under the curve of insulin (AUCI), first-phase insulin
Empirical research on the relationship between menopause and depression has found contradictory results. Some authors suggest that depression is related to menopausal symptoms and not to menopausal status per se. Our aim is to study the relationship between menopausal status and depressive symptoms in a sample (n = 728) of middle-aged Portuguese women, taking into account the presence of menopausal symptoms. Depressive symptoms were measured with the Centre for Epidemiological Studies Depression Scale (CES-D). There is a relatively high significant correlation between depressive and menopausal symptomatology (rs = .47). The increase of depressive symptomatology in perimenopause is still significant, even when adjusting for the presence of menopausal symptomatology.
Menopausal estrogen therapy has a complex balance of benefits and risks and is no longer routinely recommended for the majority of women during or after the transition to menopause. Recent findings from the Women's Health Initiative (WHI) and other studies suggest that a woman's clinical and biological characteristics may modify her health outcomes on hormone therapy (HT) and that some women may be more appropriate candidates for therapy than others. An emerging body of evidence suggests that it may be possible to identify women who are more likely to have favorable outcomes and less likely to have adverse events on HT, as well as to tailor the optimal dose, formulation, and route of delivery of treatment, by the use of individual risk stratification and a personalized approach. Several clinical characteristics that have been proposed for this purpose include a woman's age, time since menopause, symptom severity, baseline vascular health, risk for breast cancer, biomarker levels, and
Patients with type 2 diabetes mellitus (T2DM) exhibit insulin resistance associated with obesity and inflammatory response, besides an increased level of oxidative DNA damage as a consequence of the hyperglycemic condition and the generation of reactive oxygen species (ROS). In order to provide information on the mechanisms involved in the pathophysiology of T2DM, we analyzed the transcriptional expression patterns exhibited by peripheral blood mononuclear cells (PBMCs) from patients with T2DM compared to non-diabetic subjects, by investigating several biological processes: inflammatory and immune responses, responses to oxidative stress and hypoxia, fatty acid processing, and DNA repair. PBMCs were obtained from 20 T2DM patients and eight non-diabetic subjects. Total RNA was hybridized to Agilent whole human genome 444K one-color oligo-microarray. Microarray data were analyzed using the GeneSpring GX 11.0 software (Agilent). We used BRB-ArrayTools software (gene set analysis - GSA)
Coronary heart disease is the leading cause of death for both men and women in the United States. Other types of heart disease, including coronary microvascular disease and broken heart syndrome, also can affect women.
for the purpose of predicting menopause since clear markers for predicting menopause are yet to be identified. ( ... III) SUMMARY OF KEY POINTS: A4. Perimenopause is characterized by fluctuating hormone lev- els, irregular menstrual cycles, and the onset
Morcellation of the Uterus is an oncologically flawed and dangerous practice. It is incredible that the gynecological community is accepting the practice as safe. For example, the incidence of occult leiomyosarcoma is 1/400 in women who undergo hysterectomy for presumed benign fibroid disease. Morcellation leads to conversion of an early stage, contained and potentially curable uterine cancers to a deadly stage 4 cancer; that is, sarcomatosis or carcinomatosis. Morcellation is virtually never part of the informed consent process. And even if it was, the incidence of occult uterine malignancy makes it a disastrous and unethical technique. Please refer to the following link to a petition to place an immediate moratorium on this terrible practice. It is your ethical responsibility to explore this issue and help stop it: https://www.change.o...ve-hysterectomy
Has anyone tried FetalGrowth app (App Store for iPhone/iPad) ? I'm interested in using a simple and handy tool to calculate fetal percentiles, and I came across this app, which seems it does the job (plots growth charts, as well). I haven't seen anything else, besides this app, so I was wondering if there are people who have already tried it.
’Scientists have somehow missed definitions of gender in human beings,” states Dr. Makarand Fulzele. Insights gained from years of practice as surgeon makes him wonder if indeed we have overlooked facts staring in our face. Nature has a tendency to hide many secrets but at the same time it provides enough clues to unravel its mysteries. Dr. Fulzele picks up loose threads from life to stitch together the theory that man is an extension of woman in his new book, “Man Is the Extension of Woman: Know the Ultimate Truth about Yourself” (published by iUniverse). Dr. Fulzele’s book explores similarities between men and women against the backdrop of their genetic differences, physical variations, and emotional and intellectual dissimilarities. Dr. Fulzele who is a successful surgeon further explains in his book: The main hypothesis I discuss in this book is that, if a woman lives long enough she will be converted into a man physically. A similar thing can also be stated about man. It is wrong to categorize humankind into two genders as it implicates that they are extremely dissimilar and physically opposite to each other. I try to prove that man and woman are just two different stages of one developmental process. And physically they are very similar. The ideas presented may sound unconventional but Dr. Fulzele implores readers to consider his point of view with an open mind. “Your world will not change if you do not agree with me. But if you agree with me, how does it change your world? If more people agree with you and me, how does it change our world? The possibilities are limitless.” About the Author Dr. Makarand Fulzele is a successful surgeon and medical superintendent of a government hospital in Mumbai. He enjoys tapping into hidden and mysterious regions of the human mind, where many strange thoughts occur and get ignored. He is also the author of “Rainbow,” a book similarly dedicated to the spirit of light.
Nasal Surgery is the most common approach of open rhinoplasty. It is performed through incisions on the inside of the nose, as well as a single 4 or 5 mm external incision on the undersurface of the narrow area between the two nostrils. It is a reliable procedure that can dramatically improve the appearance and balance of your face.To know more..
To all the members of OB-GYN-L… Thank you for coming! I’m thrilled that you’ve decided to check out the new Forum site, and look forward to reading about what’s on your mind.
If you’re new to the ObGyn.net community... welcome aboard! You’ve just joined an outstanding group of physicians and health care professionals who have been sharing information, answering questions, and building professional relationships via the site’s listserv for nearly 20 years.
Feel free to poke around on the site to get a feel for things, or take a look at the Help Topics page for instructions on how to use the different features of the site.
A few quick tips: For those of you who like getting new Forum messages delivered directly to your inbox, the first thing you’ll want to do is click on the ‘Follow this forum’ button on the main page. You’ll have the option of getting notifications immediately, as a daily digest, a weekly digest, or only when you’re not online (which is to say, if you’re on the site when someone posts a message, you won’t be notified of it). You won’t be able to post on the site just by replying to the email, but the message will contain a link that takes you directly to the message you’d like to reply to.
You can also follow individual conversations without following the whole list by going into the topic and clicking the ‘Follow this topic’ button next to the title.
Also, in ‘My Profile’ you can:
Enter your professional information, including specialty, subspecialty, and education (by clicking ‘Edit my profile’)
See your activity on the Forum, such as what discussions you have initiated or replied to, content you’ve ‘liked,’ and activity of people you’ve made your friends
In ‘My Settings’ you can:
Add or change your photo
Edit your birthday, gender, interests, location
Create a signature for your posts
Change the types of content you get notifications for, or change the way you receive notifications
If you have questions, feel free to respond to this post or send me a direct message by clicking on the envelope icon.
Many thanks for your interest in the FetalGrowth app, it was a surprise for us to see the post Carlos has started, and those many follow-ups ! We would like to make some comments regarding our app:
Why Fetalgrowth app, in the first place? Most ultrasound equipments that compute fetal weight percentiles and most charts and calculators available on the internet rely on basic statistical models and have quite limited accuracy. This is fine for example in normal pregnancies where say, one chart gives you a figure of 40% ptile while another gives you, 60%. You 'll know you are dealing with a more or less normal fetal weight. But what happens when one calculator gives you 5% and another 25%? You will surely want to rely on a tool as accurate as possible to be certain you deal with a Small for Gestational Age case or not. In such cases Fetalgrowth will be of much help as it is an accurate tool using fully customized statistical models (you will need to input more info but calculation will be more reliable).
Customization is provided for several countries such as Spain, Sweden, Netherlands, Ireland, UK, USA, Australia, etc. If interested to include a model of your country and may provide us with pregnancies statistics for that country, please contact us at email@example.com.
Just to make sure, we will detail a bit what is actually required to add a model for a new country. We need some data (nation-wide statistics) regarding pregnancies in that country. Namely, we need a list of singleton pregnancies and twins pregnancies with the following data (this is the minimum information required):
- Mother's age - Maternal Ethnicity - Maternal Parity - Maternal Height - Maternal Weight at booking - Gestation (weeks,days) - Baby's weight at birth - Fetus Gender
We need to know if the mother suffered certain conditions that could have affected fetal development and if the pregnancy was normal or not.
A minimum of 1000 singleton cases and at least 200 twins cases would be needed to design the statistial model of birthweight and based on this model implement the calculator and growth charts.
It must not have come as a surprise to professional billers and coders that the complexities around OBGYN are beginning to take a toll on OBGYN care providers’ finances. Understanding the complexities of OBGYN, any expert will admit, is not easy as there are various rules as well as exceptions together with multiple codes for a range of medical billing services and phases involved in OBGYN. http://www.medicalbi...x?ArticleId=429
CC is a 31 year old primigravida who was referred for ultrasound at a community hospital due to suspected cardiac anomalies noted on a screening sonogram at her doctor's office. Due to concern about a probable cardiac abnormality an amniocentesis was performed at the local hospital.
Single umbilical artery color doppler, transverse scan of urinary bladder shows single umbilical artery (left), transverse section of umbilical cord showing only two vessels: one vein and one artery (right).
How Physicians Can Manage Unexpected Free Time Jennifer Frank, MD, October 22, 2013 Whether you have an unexpected patient no-show, or two hours before bed, figuring out how to spend spurts of free time can be a work-life balance stressor.